We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,407
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDHL
14001
CALL
Redhill Biopharma
RDHL
$3.67M
$295 ﹤0.01%
23
LAB icon
14002
PUT
Standard BioTools
LAB
$285M
$290 ﹤0.01%
+100
New +$262
ACIU icon
14003
PUT
AC Immune
ACIU
$248M
$285 ﹤0.01%
100
-2,000
-95% -$6.09K
OHAAW
14004
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$284 ﹤0.01%
10,252
-1,528
-13% -$83
DOGZ icon
14005
PUT
Dogness International Corp
DOGZ
$17.8M
$282 ﹤0.01%
30
-10
-25% -$133
REVBW icon
14006
Revelation Biosciences Warrant
REVBW
$279 ﹤0.01%
16,481
+1,761
+12% +$29
RFACW
14007
DELISTED
RF Acquisition Corp. Warrants
RFACW
$277 ﹤0.01%
11,088
-900
-8% -$15
INTA icon
14008
Intapp
INTA
$3.08B
$268 ﹤0.01%
8
-22,928
-100% -$837K
NUVB icon
14009
PUT
Nuvation Bio
NUVB
$2.1B
$268 ﹤0.01%
+200
New +$333
FRXB.WS
14010
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$268 ﹤0.01%
12,777
+2,186
+21% +$177
CRVS icon
14011
Corvus Pharmaceuticals
CRVS
$1.27B
$267 ﹤0.01%
+183
New +$387
BNCWW
14012
CEA Industries Inc Warrant
BNCWW
$59.3K
$261 ﹤0.01%
13,072
+2,430
+23% +$97
YI
14013
PUT
111 Inc
YI
$33.4M
$260 ﹤0.01%
10
DMAC icon
14014
CALL
DiaMedica Therapeutics
DMAC
$359M
$258 ﹤0.01%
100
-6,900
-99% -$22.2K
SCYX icon
14015
SCYNEXIS
SCYX
$50.9M
$258 ﹤0.01%
+14
New +$334
SOPH icon
14016
CALL
SOPHiA GENETICS
SOPH
$636M
$255 ﹤0.01%
100
SOPH icon
14017
PUT
SOPHiA GENETICS
SOPH
$636M
$255 ﹤0.01%
+100
New +$317
IRIX icon
14018
CALL
IRIDEX
IRIX
$14.8M
$254 ﹤0.01%
+100
New +$190
AGRIW
14019
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$252 ﹤0.01%
12,661
+1,503
+13% +$33
IRIX icon
14020
IRIDEX
IRIX
$14.8M
$251 ﹤0.01%
99
-10,943
-99% -$20.8K
KULR icon
14021
PUT
KULR Technology Group
KULR
$124M
$251 ﹤0.01%
+88
New +$501
ACDCW
14022
DELISTED
ProFrac Holding Corp. Warrant
ACDCW
$250 ﹤0.01%
48,106
+2,945
+7% +$20
APLT
14023
PUT
DELISTED
Applied Therapeutics
APLT
$249 ﹤0.01%
100
-500
-83% -$824
CSSEL
14024
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Warrant
CSSEL
$249 ﹤0.01%
23,226
-2,194
-9% -$34
AQMS icon
14025
Aqua Metals
AQMS
$10.1M
$246 ﹤0.01%
+1
New +$239

Similar funds

Citadel Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Citadel Advisors's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Citadel Advisors opened 1,407 new positions and closed 1,460 in Q3 2023.
  • Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.